Depression Treatment: Chronic and Recurrent Depression in Primary Care: Socio-Demographic Features, Morbidity, and Costs.

Chronic and recurrent depression in primary care: socio-demographic features, morbidity, and costs.

Filed under: Depression Treatment

Int J Family Med. 2012; 2012: 316409
McMahon EM, Buszewicz M, Griffin M, Beecham J, Bonin EM, Rost F, Walters K, King M

Background. Major depression is often chronic or recurrent and is usually treated within primary care. Little is known about the associated morbidity and costs. Objectives. To determine socio-demographic characteristics of people with chronic or recurrent depression in primary care and associated morbidity, service use, and costs. Method. 558 participants were recruited from 42?GP practices in the UK. All participants had a history of chronic major depression, recurrent major depression, or dysthymia. Participants completed questionnaires including the BDI-II, Work and Social Adjustment Scale, Euroquol, and Client Service Receipt Inventory documenting use of primary care, mental health, and other services. Results. The sample was characterised by high levels of depression, functional impairment, and high service use and costs. The majority (74%) had been treated with an anti-depressant, while few had seen a counsellor (15%) or a psychologist (3%) in the preceding three months. The group with chronic major depression was most depressed and impaired with highest service use, whilst those with dysthymia were least depressed, impaired, and costly to support but still had high morbidity and associated costs. Conclusion. This is a patient group with very significant morbidity and high costs. Effective interventions to reduce both are required.
HubMed – depression

 

Predictors of Treatment with Duloxetine or Venlafaxine XR among Adult Patients Treated for Depression in Primary Care Practices in the United Kingdom.

Filed under: Depression Treatment

Depress Res Treat. 2012; 2012: 815363
Shi N, Durden E, Torres A, Cao Z, Happich M

Background. Knowledge about real-world use of duloxetine and venlafaxine XR to treat depression in the UK is limited. Aims. To identify predictors of duloxetine or venlafaxine XR initiation. Method. Adult depressed patients who initiated duloxetine or venlafaxine XR between January 1, 2006 and September 30, 2007 were identified in the UK’s General Practice Research Database. Demographic and clinical predictors of treatment initiation with duloxetine and venlafaxine XR were identified using logistic regression. Results. Patients initiating duloxetine (n = 909) were 4 years older than venlafaxine XR recipients (n = 1286). Older age, preexisting unexplained pain, respiratory disease, and pre-period use of anticonvulsants, opioids, and antihyperlipidemics were associated with increased odds of initiating duloxetine compared to venlafaxine XR. Pre-period anxiety disorder was associated with decreased odds of receiving duloxetine. Conclusion. Initial treatment choice with duloxetine versus venlafaxine XR was primarily driven by patient-specific mental and medical health characteristics. General practitioners in the UK favor duloxetine over venlafaxine XR when pain conditions coexist with depression.
HubMed – depression

 

Associations between Overall and Abdominal Obesity and Suicidal Ideation among US Adult Women.

Filed under: Depression Treatment

J Obes. 2012; 2012: 263142
Zhao G, Li C, Ford ES, Tsai J, Dhingra SS, Croft JB, McKnight-Eily LR, Balluz LS

Obesity is associated with increased risks for mental disorders. This study examined associations of obesity indicators including body mass index (BMI), waist circumference, and waist-height ratio with suicidal ideation among U.S. women. We analyzed data from 3,732 nonpregnant women aged ?20 years who participated in the 2005-2008 National Health and Nutrition Examination Survey. We used anthropometric measures of weight, height, and waist circumference to calculate BMI and waist-height ratio. Suicidal ideation was assessed using the Item 9 of the Patient Health Questionnaire-9. Odds ratios with 95% conference intervals were estimated using logistic regression analyses after controlling for potential confounders. The age-adjusted prevalence of suicidal ideation was 3.0%; the prevalence increased linearly across quartiles of BMI, waist circumference, and waist-height ratio (P for linear trend <0.01 for all). The positive associations of waist circumference and waist-height ratio with suicidal ideation remained significant (P < 0.05) after adjustment for sociodemographics, lifestyle-related behavioral factors, and having either chronic conditions or current depression. However, these associations were attenuated after both chronic conditions and depression were entered into the models. Thus, the previously reported association between obesity and suicidal ideation appears to be confounded by coexistence of chronic conditions and current depression among women of the United States. HubMed – depression

 

Cardiovascular Diseases and Depression: Treatment and Prevention in by Baune

$161.63
End Date: Tuesday Aug-13-2019 0:08:45 PDT
Buy It Now for only: $161.63
Buy It Now | Add to watch list

 

Medical Psychiatry: Depression: Treatment Strategies and Management Vol. 34 2006
$14.96
End Date: Monday Aug-26-2019 10:52:28 PDT
Buy It Now for only: $14.96
Buy It Now | Add to watch list

 

The Complete Depression Treatment and Homework Planner by Arthur E. Jr. Jongsma
$50.00
End Date: Tuesday Aug-13-2019 7:40:01 PDT
Buy It Now for only: $50.00
Buy It Now | Add to watch list

 

More Depression Treatment Information…